Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza.

NCT04682444 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Respiratory Viral Infections
Human Influenza

Interventions

DRUG: Enisamium Iodide
DRUG: Placebo

Sponsor

Joint Stock Company "Farmak"